ART ICR Saliva Test To Detect Genetic... - Active Surveillan...

Active Surveillance - Prostate Cancer

678 members385 posts

ART ICR Saliva Test To Detect Genetic Variants Linked To High Risk, Aggressive PCa

RMontana profile image
0 Replies

ART ICR Saliva Test To Detect Genetic Variants Linked To High Risk, Aggressive PCa

• A spit test, where a sample can be collected at home, is more accurate at identifying future risk of prostate cancer for one group of men than the current standard blood test (PSA)

o For the men with the highest genetic risk, the PRS test falsely identified fewer people with prostate cancer than the PSA test,

o picked up people with cancer who would have been missed by the PSA test alone, and

o picked up a higher proportion of the aggressive cancers than the PSA test.

• The researchers are presenting findings from the study at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago.

o The study calculated the polygenic risk score (PRS) of 6,142 European men recruited from their GP surgeries

o The score is based on 130 genetic variations in the DNA code that are linked to prostate cancer

o an international team has identified more risk variants for men of Asian and African ancestry

• 558 men high risk men were invited to further screening, including MRI n Biopsy.

o 187 (34 per cent) with a high PRS were diagnosed with prostate cancer, vs

o 140 (25 per cent) of the 558 men who had prostate cancer found with a PSA test only.

o PRS was therefore 34% more likely to find PCa than PSA, and

> 147 (77.8 per cent) of the 187 men had a PSA below 3.0ug/L (ng/mL)

> this PSA is considered ‘normal’ and no further treatment would have followed

> 55.1% were aggressive cancers; only 35.5% of these were identified by PSA test

> PRS was 55% more effective in identifying aggressive PCa’s than PSA

• PRS test is more accurate than MRI in men with high genetic risk,

o 119 men (63.6 per cent) of the 187 had prostate cancer confirmed by a biopsy

o this PCa was not detected by the MRI.

• PRS saliva test could offer an additional screening tool to be offered to men at higher risk

• TRANSFORM trial will compare the PRS saliva test to the PSA blood test and MRI scan

• PRS is a simple, cheap, spit test used to identify men at higher risk with PCa due to their genetic makeup; an effective tool to catch the PCa early

icr.ac.uk/news-archive/asco...

Written by
RMontana profile image
RMontana
To view profiles and participate in discussions please or .
Read more about...

Not what you're looking for?

You may also like...

ART AACR Journal ; Effect of Sulforaphane in Men with BCR after Radical Prostatectomy

I have posted an NIH study with similar findings and have noted that I have taken 20mg of...
RMontana profile image

ART How to Increase TET Naturally; Dr Rena Malik, M.D.

ART How to Increase TET Naturally; Dr Rena Malik, M.D. Here is a good set of 5 recommendations on...
RMontana profile image

Contrast MRI vs biopsy

Just wanted to share my experience with contrast pelvic/prostate 3T MRI and prostate 14 core biopsy...
Chumpsteak profile image

Most Recent MRI

Hello everyone, I am 72 and have been on active surveillance for prostate cancer since I was...
ironmanburg profile image

Biopsies

I am nine years out since diagnosis of a very low-risk Gleason 6 tumor. It was found in a single...
AS2010 profile image

Moderation team

Bethishere profile image
BethishereAdministrator
Number6 profile image
Number6Administrator
Darryl profile image
DarrylPartner

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.